Stay updated on DLL3-Expressing Advanced Cancer Clinical Trial

Sign up to get notified when there's something new on the DLL3-Expressing Advanced Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DLL3-Expressing Advanced Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The record now presents details for a Phase 1/2 study of gocatamig, alone or with other therapies, in advanced DLL3-expressing cancers. It includes participant eligibility, study sites, outcome measures, record history, and information about data sharing.
    Difference
    87%
    Check dated 2026-11-10T20:21:29.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T20:23:21.000Z thumbnail image
  3. Check
    27 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The site revision number also advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T20:42:50.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T21:35:47.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the usual study record content. This blocks access to the study details and navigation on that page.
    Difference
    23%
    Check dated 2026-09-22T22:24:50.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.6 to v3.7.0. This indicates a recent update to the page content or metadata.
    Difference
    0.0%
    Check dated 2026-09-15T21:43:09.000Z thumbnail image

Stay in the know with updates to DLL3-Expressing Advanced Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DLL3-Expressing Advanced Cancer Clinical Trial page.